News Scan

Premium

MDS Forms Committee to Review 'Alternatives'

MDS this week said that it has formed a committee of independent directors to support the firm's ongoing process of "reviewing alternatives to improve shareholder value."

The committee includes William Anderson, Robert Luba, James MacDonald, and Gregory Spivy, all of whom are independent of management of the company. In addition to the new committee, investment banks Goldman Sachs and RBC Capital Markets are assisting MDS as financial advisors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Scientific American reports that environmental DNA sampling can detect invasive brown marmorated stinkbugs before they've fully invaded a farm.